Research record
Oxygen therapy / hyperbaric oxygen in melanoma context
If oxygen or HBOT is mentioned, separate supportive-care use from anti-cancer treatment claims and ask for the exact indication.
What this is
If oxygen or HBOT is mentioned, separate supportive-care use from anti-cancer treatment claims and ask for the exact indication.
Why it may come up
- supportive care question
- radiation injury question
- non-standard cancer-treatment claim
What not to assume
- Oxygen therapy is not listed as a melanoma treatment option in MatchMedi.
- HBOT should not be framed as proven to treat melanoma.
- Supportive-care oxygen decisions belong with the treating team.
At a glance
Oxygen therapy / hyperbaric oxygen in melanoma context
- Type
- supportive-care
- Mutation result
- any
- Where
- Global
- Evidence status
- Source gives context
- Last checked
- 2026-05-21
What we know
- NCI's drug dictionary describes hyperbaric oxygen as oxygen given under higher pressure and notes radiation/chemotherapy-sensitizing and radiation-injury-healing contexts.
- NCI supportive-care PDQ discusses oxygen for cancer patients with hypoxemia and dyspnea, while noting limits when hypoxemia is not present.
What is unclear
- A public source-backed melanoma treatment role for HBOT is not established in this database.
- Claims that oxygen therapy kills melanoma or reverses resistance should stay out of patient pages unless backed by a specific trial or guideline source.
Questions to ask
- Is oxygen being discussed for low blood oxygen, breathlessness, wound/radiation injury, or cancer treatment?
- Is this standard supportive care, HBOT, or a trial?
- Are there treatment interactions or reasons this would be unsafe in this situation?